Ex parte YAMAMOTO - Page 4


                  Appeal No. 1999-1389                                                                                        
                  Application No. 08/618,485                                                                                  
                         In our opinion, given that appellant had notice of the typographical error in the                    
                  Yamamoto reference designation and responded to the examiner’s rejection in view                            
                  of the correct Yamamoto reference, we find that the typographical error on behalf of                        
                  the examiner did not prejudice appellant’s case.  According we find the do not Final                        
                  Rejection fatally flawed by the examiner’s typographical error.  Therefore, we move                         
                  forward to the merits of the examiner’s rejection.                                                          
                         According to the examiner (Answer, page 3) Yamamoto disclose “a process                              
                  of converting glycosylated Gc protein obtained from pooled blood to a highly potent                         
                  macrophage activating factor (GcMAF) by contacting Gc protein with immobilized                              
                  ß-galactosidase and sialidase.”  The examiner explains (Answer, page 4) that                                
                  Yamamoto discloses “that Gc protein is also known as vitamin D-binding protein                              
                  and that the nucleotide and amino acid sequences of Gc protein [including domain                            
                  III] was reported by Cooke.”  The examiner relies on Luckow (Answer, page 4) to                             
                  teach “a process for the abundant expression of exogenous proteins in insect cells                          
                  using baculovirus expression vectors.”                                                                      
                         The examiner concludes (pages 5-6) that:                                                             
                                 One of ordinary skill in the art would be motivated to combine                               
                         these teachings because cloning Gc protein in a baculovirus vector                                   
                         facilitates the abundant and economical expression of a glycosylated                                 
                         Gc protein that is antigenically, immunogenically, and functionally                                  
                         similar to its counter part isolated from natural sources on a scale that                            
                         is not technically or economically feasible with other expression                                    
                         systems, and because the cloned Gc protein could be converted to                                     
                         GcMAF, a highly potent macrophage activating factor, which has utility                               
                         as a therapeutic agent for inducing macrophage activation, as taught                                 
                         by Yamamoto et al. …                                                                                 
                                 Furthermore, it would have been obvious to one of ordinary                                   
                         skill in the art at the time of Appellant’s invention to clone the cDNA                              
                         encoding domain III of the Gc protein, as taught by Cooke et al., into a                             

                                                              4                                                               



Page:  Previous  1  2  3  4  5  6  7  8  Next 

Last modified: November 3, 2007